enprofylline has been researched along with mrs 1754 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobson, KA; Kim, HS; Kim, SA; Linden, J; Marshall, MA; Melman, N; Müller, CE | 1 |
| Elzein, E; Gimbel, A; Kalla, RV; Li, X; Maa, T; Palle, V; Perry, T; Varkhedkar, V; Zablocki, J; Zeng, D | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Bertarelli, DC; Borrmann, T; Florin, NC; Hinz, S; Li, W; Müller, CE; Scheiff, AB | 1 |
| Azuaje, J; Carbajales, C; Crespo, A; El Maatougui, A; Escalante, L; García-Mera, X; González-Gómez, M; Gutiérrez-de-Terán, H; Miguez, G; Sotelo, E | 1 |
| Barawkar, DA; Basu, S; Bedse, G; Bonagiri, R; Chaturvedi, S; Chugh, A; Dusange, S; Ghosh, I; Goswami, A; Gundu, J; Jadhav, D; Karande, V; Kulkarni, A; Kumar, S; Menon, S; Mookhtiar, KA; Mukhopadhyay, P; Paliwal, S; Palle, VP; Panmand, A; Patel, M; Prasad, V; Quraishi, A; Ramdas, V; Reddy, BS; Rouduri, S; Thakre, R; Thorat, S; Waman, Y | 1 |
| Gaba, S; Gupta, GD; Monga, V; Patel, R; Saini, A; Singh, G | 1 |
1 review(s) available for enprofylline and mrs 1754
| Article | Year |
|---|---|
Adenosine receptor antagonists: Recent advances and therapeutic perspective.
Topics: Dose-Response Relationship, Drug; Humans; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Structure-Activity Relationship | 2022 |
6 other study(ies) available for enprofylline and mrs 1754
| Article | Year |
|---|---|
Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.
Topics: Animals; Binding, Competitive; Cell Line; Cloning, Molecular; Humans; Ligands; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B; Receptors, Purinergic P1; Recombinant Proteins; Structure-Activity Relationship; Xanthines | 2002 |
Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists.
Topics: Adenosine A2 Receptor Antagonists; Animals; Cell Line; Cricetinae; Cricetulus; Humans; Pyrazoles; Radioligand Assay; Theophylline; Xanthines | 2006 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.
Topics: Adenosine A2 Receptor Antagonists; Animals; Drug Design; Humans; Kinetics; Ligands; Mice; Protein Binding; Radioligand Assay; Rats; Receptor, Adenosine A2B; Xanthines | 2009 |
Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes.
Topics: Adenosine A2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Structure; Pyrimidinones; Receptor, Adenosine A2B; Structure-Activity Relationship | 2016 |
A
Topics: Adenosine A2 Receptor Antagonists; Animals; Brain; Chemistry Techniques, Synthetic; Drug Design; Male; Mice; Receptor, Adenosine A2B; Structure-Activity Relationship; Xanthine | 2017 |